Standards Development for Regenerative Medicine Therapies

Inactive
Notice ID:FDA-SSN-1224405

Standards Development for Regenerative Medicine Therapies, per the attached source sought notice FDA-SSN-1224405.

Department/Ind.Agency Subtier Office
HEALTH AND HUMAN SERVICES, DEPARTMENT OF FOOD AND DRUG ADMINISTRATION FDA OFFICE OF ACQ GRANT SVCS
  PSC   OTHER SPECIAL STUDIES AND ANALYSES


Data sourced from SAM.gov. View Official Posting »